NasdaqGS - Delayed Quote USD

REGENXBIO Inc. (RGNX)

7.52
+0.37
+(5.17%)
At close: May 9 at 4:00:00 PM EDT
7.56
+0.04
+(0.53%)
After hours: May 9 at 6:15:27 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
83,328
83,328
90,242
112,724
470,347
Cost of Revenue
33,567
33,567
37,213
54,545
51,833
Gross Profit
49,761
49,761
53,029
58,179
418,514
Operating Expense
281,006
281,006
321,157
321,055
258,534
Operating Income
-231,245
-231,245
-268,128
-262,876
159,980
Net Non Operating Interest Income Expense
-12,485
-12,485
-6,837
-22,912
-25,558
Other Income Expense
16,628
16,628
11,319
5,383
6,825
Pretax Income
-227,102
-227,102
-263,646
-280,405
141,247
Tax Provision
0
0
-152
-84
13,407
Net Income Common Stockholders
-227,102
-227,102
-263,494
-280,321
127,840
Diluted NI Available to Com Stockholders
-227,102
-227,102
-263,494
-280,321
127,840
Basic EPS
-5.01
-4.59
-6.02
-6.50
3.01
Diluted EPS
-5.01
-4.59
-6.02
-6.50
2.91
Basic Average Shares
47,789.25
49,509
43,734
43,152
42,438
Diluted Average Shares
47,789.25
49,509
43,734
43,152
43,913
Total Operating Income as Reported
-233,346
-233,346
-268,128
-262,876
159,980
Total Expenses
314,573
314,573
358,370
375,600
310,367
Net Income from Continuing & Discontinued Operation
-227,102
-227,102
-263,494
-280,321
127,840
Normalized Income
-243,730
-243,730
-274,806.47
-285,702.39
121,662.82
Interest Income
174
174
25
342
719
Interest Expense
12,659
12,659
6,862
23,254
26,277
Net Interest Income
-12,485
-12,485
-6,837
-22,912
-25,558
EBIT
-214,443
-214,443
-256,784
-257,151
167,524
EBITDA
-198,228
-198,228
-239,464
-244,242
177,088
Reconciled Cost of Revenue
33,567
33,567
37,213
54,545
51,833
Reconciled Depreciation
16,215
16,215
17,320
12,909
9,564
Net Income from Continuing Operation Net Minority Interest
-227,102
-227,102
-263,494
-280,321
127,840
Total Unusual Items Excluding Goodwill
16,628
16,628
11,319
5,383
6,825
Total Unusual Items
16,628
16,628
11,319
5,383
6,825
Normalized EBITDA
-214,856
-214,856
-250,783
-249,625
170,263
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
6.53
1.61
647.82
12/31/2021 - 9/17/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QURE uniQure N.V.
12.79
+4.41%
 
RCKT Rocket Pharmaceuticals, Inc.
6.99
-0.71%
 
SLDB Solid Biosciences Inc.
2.7600
-0.36%
 
FDMT 4D Molecular Therapeutics, Inc.
3.0800
-4.94%
 
LXEO Lexeo Therapeutics, Inc.
2.6900
-10.33%
 
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
 
CYTK Cytokinetics, Incorporated
31.70
-2.42%
 
MGTX MeiraGTx Holdings plc
5.42
-0.91%
 
IDYA IDEAYA Biosciences, Inc.
17.42
-4.18%
 
VYGR Voyager Therapeutics, Inc.
3.1700
-7.58%